The University of Bristol's Langford Veterinary Services (LVS) has announced the completion of its new clinical facilities.
The first phase of the £13 million development includes a new small animal surgery building, comprising five theatres, an ICU, a dedicated anaesthesia induction and recovery and an imaging suite.
The imaging suite comprises a 16-slice CT scanner, for small animals and horses, conventional digital radiography with a DR system, a high-resolution fluoroscopy, diagnostic ultrasound, echocardiography, scintigraphy and a high resolution 1.5 tesla MRI scanner available seven days a week.
Lynne Hill, Chief Executive of LVS, said: "The new facility provides state-of-the art diagnostic imaging facilities at all times, to help the animals under our care."
LVS highlights the case of Gainsborough, an eight-year-old Irish draught gelding, to illustrate the benefits of its new facilities. The horse, used for jumping and endurance, was initially presented to the Equine Hospital in October 2010, with clinical signs including nasal airflow obstruction and discharge, which was limiting his athletic capabilities.
Using videoendoscopy and radiography, a space-occupying mass was diagnosed in the paranasal sinuses impinging into the nasal cavity. With the horse conscious, but sedated, using regional local anaesthetic nerve blocks, the bulk of the mass was removed and he returned to work. However, the owner reported a recurrence of the clinical signs and he was returned to the clinic for reassessment.
The new imaging suite, only one of a few such units in the UK, has been adapted to enable the imaging of a horse's head while conscious using a frictionless air plinth. The adaptation allows detailed imaging of both bone and soft tissue structures within a horse's head, without requiring a general anaesthetic.
Using the new imaging suite, Gainsborough's CT examination revealed a portion of the mass, which had been inaccessible to the previous keyhole surgery, had expanded into the nasal cavity. The detail of the images enabled careful planning of a second operation that facilitated removal of the large remnant of the mass, which appeared to be benign, with minimal collateral trauma.
In addition to imaging the heads of conscious horses, dogs and cats are able to undergo complete body scans using the same unit while anaesthetised. As well as enabling detection and diagnosis of lesions without invasive or painful tests at an earlier stage, the unit will facilitate operative planning and add to the body of knowledge of disease pathogenesis.
For more information about LVS, visit: http://www.langfordvets.co.uk/
The hands-on course, which is worth 7 CPD hours, has been organised by Dr Nicola M Parry, Recognised Specialist in Pathology at the University of Surrey School of Veterinary Medicine. It will combine lectures, practicals, and a Q&A session to enable delegates to carry out a post-mortem, identify common (and not so common) pathologies, and draw conclusions about the cause of death.
The morning lectures will provide an overview of techniques that focus on how to approach the post-mortem examination of the adult horse and the foetus/foal, as well as how to examine the placenta. Potential findings will be discussed as well as some pitfalls to avoid during the post-mortem examination, and how to optimise sample submission. The lectures will be recorded, enabling sessions to be reviewed later.
Delegates will spend the afternoon in the post-mortem room, examining macroscopic specimens and learning practical approaches to a post-mortem examination in the field, and the collection of key specimens. The day will close with a Q&A session.
Speakers Dr Fabio Del Piero from the Louisiana State University and Dr Marvin J Firth from the University of Surrey will help delegates to:
Sarah Gaspar, the Learning Manager at BEVA said: “If you have ever been called out to a dead horse to find a distraught owner and not been sure how to identify the cause, this course is for you. We can’t remember any course ever having been run on this topic in the UK before; it is likely to be very popular so be quick to book.”
To find out more and to book click here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1582
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
References
BCF has announced the launch of the wireless Cuattro Slate 4 equine DR system.
BCF says the new system is available with an Automatic Exposure Detection (AED) panel, which means the plate automatically recognises the radiation from the generator, with no need for a sync cable.
Gavin Mitchell from BCF said: "This system now makes the connection from any generator to the plate and from plate to tablet now wireless. This is the new revolution for equine DR. Our rugged tablet design makes it easy to show your client your images. All you need to carry with you is the plate, tablet and generator. So much lighter to transport than previous DR systems and now also easier to move around the horse."
Sarah O'Grady from BCF added: "The powerful Cuattro software is so intuitive to use, allowing you to easily customise how your image looks. A simple three step process to take an image and just one button press to back-up images to PACS or the Cloud, makes the Slate so easy to use. If you are considering upgrading to DR or replacing your old DR system, then make sure you try out the new Slate 4."
For more information, visit www.bcftechnology.com or ask your local Account Manager for a free trial.
Vetoquinol has announced the launch of Chrysanphyton, the latest addition to its range of Equistro feeding stuffs for horses.
Vetoquinol says Chrysanphyton is recommended for horses where support of a normal blood flow to the hoof is important. It contains Chrysantellum americanum, blackcurrant and hazelnut extracts which, according to the company, provide a rich source of nutrient bioflavanoids and vitamins.
The recommended administration of Chrysanphyton is 10ml twice a day in horses (500kg) and 5ml twice a day in ponies with the 1000ml pack lasting 50 or 100 days respectively.
A product information sheet is available on the Equistro website www.equistro.co.uk
For further information contact your local Vétoquinol Territory Manager.
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
This year’s programme includes five live streams running in parallel throughout the conference with clinical research presentations also returning after the Covid-enforced hiatus.
The first plenary lecture will be presented by Pat McCue who will review events that have shaped current practice in equine reproduction before looking at what the future holds.
The second plenary lecture, being delivered by Celia Marr, will look at 'evidence in perinatology'.
David Lloyd, Congress Scientific Programme Chair, said: “Whilst we are sure most delegates will be clamouring to attend the lectures and discussions in Liverpool in person, the programme also includes a virtual stream available live online.
“Also, to help reduce our carbon footprint, we are holding one virtual session concurrently across all lecture theatres.
"Global leaders in the field of infectious disease, imaging, nursing, reproduction and sports medicine and rehabilitation, will present virtually to the lecture hall rather than travelling to the congress.
"This session will have 25 of the “best of the best” speakers, presenting and discussing topics that challenge us in practice.”
Early bird tickets for BEVA Congress are available from 28th February 2022.
Early bird BEVA member prices are £499 for vets and £187 for vet nurses for all three days (with concessions available for those in their first three years post graduation or on a lower salary).
Virtual tickets are £199 for vets and £40 for nurses.
BEVA has a 'peace of mind' bookings policy to reassure those who are concerned that the Covid-19 situation may change between booking their ticket and the event.
For more information, or to book, visit http://www.bevacongress.org/
They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
Horiba Medical - UK has launched MLT-Diode Laser Systems, specifically designed for veterinary use, as part of its portfolio of animal healthcare products.
According to the company, the MLT-Diode Lasers are highly versatile and can be used in a variety of veterinary applications including surgery, endoscopy, dentistry and irradiation.
The two models, the MLT-Diode Laser Classic and Premium, both feature touch screen controls and are adaptable to each users individual preferences. Designed with small animal practices in mind, the Classic has a performance out-put of 8 watts whilst the more powerful Premium model is for equine medicine with an output of 15 watts. The system is mounted on a mobile cart with a protection case, allowing the whole system to be moved between treatment rooms and enabling near patient application.
Horiba Medical will be exhibiting the MLT-Diode Laser Systems at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
From early 2025, all vets, nurses and technicians will be required to wear a hard hat in the vicinity of a horse, pony or donkey – whether in practice, on a yard, or at a client’s premises.
It follows a three-year research project collaborating with the University of Liverpool which revealed that 90% of veterinary clinicians have experienced an injury during their career.
It is hoped that the move will reduce injuries to the head – one of the most common traumas to be suffered by equine vets identified by the research, usually sustained when examining distal limbs. CVS says that in the US, equine vets sustain on average eight serious injuries during their career, making it the second highest profession for non-fatal injuries.
The University of Liverpool research found that over 25% of equine vet injuries have led to hospital attendance. Dr. John Tulloch, Lecturer and European Specialist in Veterinary Public Health at the University of Liverpool, who led the research, said: “Vet visits are not an ‘everyday activity’ for a horse.
"As a result, many horses will be on heightened alert, and some may be more prone to unpredictable behaviour. “Vets are often in a vulnerable situation when examining a horse.
"And it’s difficult to pick up on a horses’ signals, especially when examining areas such as distal limbs. “Our research found that many injuries happen when a horse kicks or pushes a person over and the person’s head makes impact with the ground.
"So, wearing a hard hat will be a big step towards preventing traumatic head injuries if this were to happen.” Sophie Ignarski, Equine Director at CVS said: “All of our clinicians are at risk in their day-to-day work – whether they are newly qualified or very experienced.
"Other colleagues including nurses, vet techs and patient care assistants are similarly vulnerable. “We decided to make wearing of hard hats mandatory in order to protect all of our colleagues and minimise the potential risk of head injury, understanding it can never be fully eliminated.
"We recognise that this policy shift represents a degree of change but hope that it serves to further support and progress the equine veterinary industry more widely. “Our policy is evidence-based, utilising three years of rigorous research, and we will continue our efforts in the future to grow our knowledge and understanding of this important area.
"By doing so, we join other industries – such as construction – who have already adopted similar changes to the extent they are now established in their culture.”
https://www.sciencedirect.com/science/article/pii/S0167587725001266
Mrs Jill Nute has been invested as president of the RCVS at the AGM and Awards Day, held on 4th July in London.
Mrs Nute graduated from Liverpool University in 1970 and initially assisted in mixed practice in the Lake District, Droitwich and Leominster. In 1976, she established a mixed practice with her husband Geoff, a fellow Liverpool graduate, in Wadebridge, Cornwall.
The practice is now an eight-veterinary surgeon concern, a veterinary nurse Training Practice, an RCVS Accredited Tier 2 Small Animal General Practice and Farm Animal General Practice, and an equine practice accredited to Tier 1; it is also a Meat Hygiene Service approved contractor.
Mrs Nute has been an RCVS Council member since 1993, serving on all of its committees. She has chaired many of these committees and additional working parties, including the Advisory and Public Affairs Committees. She served on the Officer team as Treasurer for three years, from 1996-1999, and is currently Chairman of the Practice Standards Group. Spending several years on the Councils of the British Veterinary Association and the Society of Practising Veterinary Surgeons (SPVS), she was elected President of SPVS in 1991.
RCVS Day also brought other changes to the RCVS Officer team: Dr Bob Moore, outgoing President, became Senior Vice-President, and Professor Sandy Trees took up the role of Junior Vice-President.
Professor Sheila Crispin stood down as Senior Vice-President, with Dr Moore commenting that: “The veterinary profession is privileged to have such a knowledgeable and committed advocate.”
Retiring Council members included David McDowell, Debby Reynolds, Neil Smith and Wendy Harrison. New lay observer to the Preliminary Investigation Committee, Catherine Harvey, will replace retiring observer Diane Mark. The President paid particular tribute to long-standing Council member and past-President Stephen Ware, who retires from Council but will remain active in veterinary politics as Vice-President and Treasurer of the Federation of Veterinarians in Europe, he also remains Chairman of the RCVS Trust.
As part of the AGM, newly-elected Council members Richard Stephenson, Charles Gruchy and Bertie Ellis were welcomed. A fourth new member, Catherine Goldie, was not present. It was also announced that Professor Michael Herrtage and Professor Duncan Maskell have been reappointed for further four-year periods by the University of Cambridge, and Professor Sandy Tress has been reappointed for the same term by the University of Liverpool.
Dot Creighton was re-elected to the Veterinary Nurses Council and Katherine Kissick was elected for the first time. New lay member Penelope Swindlehurst and appointed veterinary surgeon Helen Torrington were also welcomed to the VN Council and the President thanked retiring VN Council members Diane Guinan, Donna Hunter and Neil Smith.
President Dr Bob Moore conferred a range of awards, including an Honorary Associateship upon Petplan and Petplan Trust founders Mrs Patsy Bloom and Mr David Simpson who, he said, have had a “remarkable effect on the veterinary profession, animals and their owners.”
Honorary Associateship was also awarded to Mr Geoff Davies, who has dedicated his 30-year career at the University of Bristol Veterinary School to the training, support and development of future veterinary surgeons. He has also served as a valued member of the RCVS Extra-Mural Studies Committee for many years. “It is his enormous contribution in supporting and encouraging the students that is being recognised today,”said Dr Moore.
Honorary Fellowships were awarded to Mr Gary Clayton Jones, Professor Paul Flecknell and Dr Christine Gibbs, and the Dame Olga Uvarov Award, a cash prize for a researcher under the age of 40, was awarded on behalf of the RCVS Trust to Dr Harriet Smythe (in her absence)
The article argues that as the equine influenza (EI) vaccine supply returns to normal, there is sound scientific evidence why bi-annual vaccination schedules should be re-implemented promptly.
Whilst the scale and number of outbreaks has been relatively small since the introduction of mandatory EI vaccination by most competitive equestrian disciplines in the 1980s, disease events such as those experienced in the UK in 1989, 2003 and most recently in 2019 have demonstrated EI’s epidemic potential, even in vaccinated horse populations.
In their article 'Equine influenza bi-annual boosters: what does the evidence tell us?' Victoria Colgate and Richard Newton discuss what has been learnt from previous outbreaks and explain the evidence from mathematical models to show why bi-annual boosters are beneficial.
The authors say that epidemiological data from previous natural EI outbreaks have repeatedly demonstrated the impermanent nature of the protection provided by vaccination and observational field studies have repeatedly highlighted the potential for 12-monthly boosters to leave a vulnerable immunity gap at both the individual animal and population level.
Mathematical models of EI transmission confirm that six-monthly rather than annual EI booster vaccinations are preferable to establish and maintain effective population level immunity to EI.
Ideally vaccine strains should be updated in a timely manner to ensure inclusion of the most epidemiologically-relevant strains, however, this is a slow and expensive process for equine vaccine manufacturers.
In the absence of updated vaccine strains, bi-annual vaccination is strongly recommended to help compensate for antigenic drift between vaccine and circulating EI viral strains
Professor Celia Marr, Editor of the EVJ said: “Although the recent EI vaccine shortage has necessitated a temporary relaxation of competition vaccine schedules, we must now renew the message that six-monthly boosters are optimal and necessary.”
The Editorial can be found at https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13898 and is free to view.
Two related articles can be found here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13874 and here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13885
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
The UK's first online gastric ulcer risk assessment for horse owners has just been launched as part of the 2009 Gastric Ulcer Awareness Month (GUAM), organised by Merial Equine Health.
Merial has developed the risk online questionnaire to enable owners to evaluate their horse's risk of ulcers. By logging on to the website http://www.gastriculcerrisk.co.uk/, owners, trainers and riders can complete a form which then returns the results via email. Where an animal is considered to be at medium to high risk, owners will be advised to consult their veterinary practice.
The company's Dr Emma Batson said: "Since the first GUAM in 2007, significant progress has been made in developing awareness and understanding of equine gastric ulcer syndrome.
"However there is still more to do! Our goal is to move gastric ulcers further up the diagnostic process, such that the condition is an early consideration for all horses presented with the vague symptoms associated with ulceration. We know that due to the vague nature of the symptoms, many of horses are suspected of other ailments such as back and teeth problems, general poor performance, or behavioural issues prior to being diagnosed with ulcers.
"This new initiative has been developed through consultation with practising internal medicine specialists. We hope it will help to highlight more cases and encourage clients into the practice with horses that are at genuine risk of ulcers. Further diagnosis, treatment and management measures can then be considered in consultation with the client.
"The website also has a veterinary page so that follow up information and any gastroscopy results can be recorded by the vet. We hope that this feedback will help generate some valuable data for the industry."
To help you promote this initiative, Merial has produced an impactful poster for use in practice waiting rooms, along with educational literature. The poster will be available as a loose insert in various publications during April and May.
For those practices which require a referral scoping service, Merial can put you in touch with three specialist consultants; Rachael Conwell (North) Dr.Tim Brazil (Midlands/nationwide) and Richard Hepburn (South West) who each provide a mobile scoping clinic.
Merial is also promising support for the mobile scoping service for the five practices that direct the largest number of clients to http://www.gastriculcerrisk.co.uk/
A number of events are also taking place during the month for vets, trainers and horse owners, including the following CPD events:
GUAM is supported by BEVA and Dr Batson hopes that the 2009 initiatives will further boost awareness, understanding and diagnosis of this underrated condition.
Janssen Animal Health has launched a range of skincare products - Cavalesse® and Cavalesse® Topical - to help maintain and support a healthy skin in horses prone to summer skin allergies.
According to the company, summer skin allergies, including sweet itch, which is caused by reactions to bites from Culicoides midges, can be serious and frustrating conditions that affect three to five per cent of all horses in the UK. These allergies can be difficult to manage and are often a real challenge for both horse owners and vets alike.
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including Nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. The supplement helps horses maintain a healthy skin by reducing histamine release within the skin, moderating the excessive immune response within the skin, reducing anti-inflammatory reactions and suppressing antigen induced transformation.
To complete the Cavalesse skin management range, Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
Helen Goldberg, marketing manager at Janssen Animal Health said: "Summer skin allergies, such as sweet itch, are frustrating conditions that can be difficult to treat. To help prevent the disease, horses are often fully blanketed while out at grass, given limited access to pasture or covered with insect repellents, while treatment has included antihistamines and corticosteroids which can have side-effects.
"Only available via veterinary wholesalers, the Cavalesse range of products will enable owners to protect their horses from the inside, whilst maintaining a healthy skin from the outside."
2ml of Cavalesse should be administered to horses and ponies weighing less than 500kg daily, while horses weighing more than 500kg should be given 3ml per day. Cavalesse Topical should be applied to the skin according to requirements.
For further information, please contact your Janssen Animal Health account manager or phone 01494 567555.
I'm delighted to welcome Celia Marr from Rossdales and Edd Knowles from Bell Equine, who have kindly agreed to be our contributing experts. They'll drop in from time to time to add anything helpful they can to the forum discussions.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
All members of the site with an interest in equine medicine are now invited to press the join button on the left hand side of the group home page (when viewed on tablet or bigger). You may also wish to select the option to receive a daily or weekly digest of new content by email, which you can cancel at any time.
Equine is the third special interest group launched on VetSurgeon.org. The other two are Small Animal Medicine and Small Animal Dentistry.
Dechra Pharmaceuticals PLC has announced that it has acquired the entire issued share capital of Genitrix Limited ("Genitrix") from its owner managers for an initial cash consideration of £5.4 million, with a further £0.8 million being payable upon achievement of specific milestones.
Dechra says the acquisition of Genitrix is consistent with its strategy to grow its international veterinary pharmaceutical business. In the year ended 31 March 2010, Genitrix achieved revenues of £2.4 million.
Ian Page, Chief Executive of Dechra, said: "Genitrix range of equine and companion animal products enhances and complements our UK product portfolio. Furthermore the recently approved canine epilepsy product, Libromide, provides future growth opportunities through potential mutual recognition in Europe. The acquisition is expected to be earnings enhancing in the first full year following ownership."
Hand-mouldable into any shape, Hoof Repair is used to create prosthetic hoof extensions and additions that restore foot integrity.
The company says there is no exothermic reaction when the thermoplastic hardens, which eliminates issues caused by excessive heat and makes the product suitable for treating acute laminitis, cracked hooves and horses that have lost a lot of hoof.
When used with Imprint Structural Adhesive, Hoof Repair forms a bond with hoof wall which can be nailed into and rasped, and will stay in place as hoof grows. Hoof Repair is also suitable for treating foal foot deformities.
The company says Hoof Repair is often used in conjunction with Imprint shoes, which are made of the same low melt, long lasting thermoplastic. It allows extensions to be made to the shoes and together the Imprint system protects and supports the hoof allowing the foot to flex and move freely.
Andrew Poynton, Imprint’s Inventor said: "Hoof Repair forms part of a foot care system that has been developed over 20 years by farriers in association with veterinary surgeons. Hoof Repair assimilates hooves precisely to retain the foot integrity and it is particularly useful for treating acute laminitis and cracked or badly damaged hooves."
Vets with Horsepower is organised annually by Professor Derek Knottenbelt to help raise funds for equine and human charities around the world.
This year the group undertook an endurance motorbike trip of over 1600 miles: from the UK to Germany, across Scandinavia and back, hosting education events for equine vets along the way to raise funds for four charities including BEVA's Power for Ukraine.
BEVA Council member Alison Talbot, said: “Thanks to the generosity of equine vets in the UK we had just hit the halfway mark of raising £10,000, before Vets with Horsepower set off on their epic Scandinavian mission.
"We are so grateful for their donation of £9922 which means we can now buy another five generators, to help twice as many vets and horses in extremely difficult circumstances during enforced power cuts."
The generators will be transported to a collection point in Poland and then on to Ukraine in time for winter.
Donations to the BEVA Trust Power To Ukraine appeal can be made here: https://www.justgiving.com/campaign/powertoukraine
Any surplus funds will be added to the general fund to support equids in Ukraine.
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
David says that whilst he was out there, he was told about attacks by Russian forces on stables in Bucha, Irpin and other equestrian premises north of Kyiv.
Ukraine vet Anatoly Levitsky who is working in Kyiv, said: “Not very big horse club was not far from Borodianka and owners were using their horses for hippotherapy of children with different pathologies.
"When war started, the lady who owned the stable and her child emigrated to Poland and her husband was conscripted into Ukrainian army.
"When Russian bandits in army uniform came to the village, they set fire to the stable and started shooting the horses that tried to escape.”
“Some horses ran away, others were wounded, and some were burned down.
"After the building was burned, Russian soldiers went away and horses that escaped were wandering around the village and trying to find the feed.
"Step by step, people living in the village collected the horses and keep one or two horses in their yards.”
David said: “It is hard to understand what could motivate anyone to perform these deliberate acts of cruelty.
"Random shootings, stabbings and burnings are widely reported and pictured on social media, we have no idea how many horses are dead and how many injured, but it has to be a significant number.
“Some of the lorry drivers I have met coming out have been shot at, shelled and beaten up, evacuating surviving horses.
"They are taking risks that we would consider totally unacceptable to move animals out and supplies in.
"I have nothing but admiration for the bravery of the Ukrainian people.”
“Ever conscious that there is an equal humanitarian need you feel very small and rather cowardly that you aren’t permitted to go into Ukraine to help the people and animals that require treatment.”
The British Equine Veterinary Association and American Association of Equine Practitioners are working together to support vets in Ukraine.
They say that they are not allowed to provide direct practical help, but they are doing what they can to get veterinary and humanitarian supplies to the vets they are in contact with.
They are also working to establish safe stables in the West of Ukraine to get horses and their owners away from likely areas of combat in the East.
Previously people have had no option but to turn horses into the woods prior to fleeing or they have stayed to look after their animals despite the risks to themselves.
BEVA, in association with the British Equestrians for Ukraine Fund, is calling for urgent support to help fund veterinary treatment, supplies and the safe relocation of Ukraine’s endangered horses.
To do this they need your urgent support. To make a donation visit https://www.worldhorsewelfare.org/support-us/appeals/british-equestrians-for-ukraine-fund.
To find out more you can listen to a podcast from David Rendle here https://beva.podbean.com/e/bevapod-episode-13/
Photo: Stabling reportedly burned down by Russian soldiers
The Association is also encouraging horse owners to join in the celebrations by sharing birthday cakes with their vet or veterinary practice.
BEVA President Huw Griffiths said: "Our 60 faces initiative celebrates some of the many outstanding people who have left an indelible mark on the profession and whose actions complement BEVA’s work in championing progress and/or diversity."
The list of 60 faces, which were nominated by BEVA members, showcases people who have inspired, influenced and progressed the equine veterinary profession for the better.
The faces range from 16th Century humanist Thomas Blundeville to 21st Century social media entrepreneur Ebony Escalona.
Every day for a month, two faces will be released on BEVA’s social media channels.
Huw added: “It was a really tough challenge to whittle the list down to 60 people as all of the nominees were exceptional individuals.
“The list showcases some of the best-known names in the industry as well as some heroes whose stories are less well known or who have been consigned to history.
“It’s not a “Top 60”, nor are all the faces vets, but it does highlight the breadth of people who have impacted what we do.
"We hope you will enjoy reading about them and we hope our lovely clients will join in the celebrations during the week starting 18th November by sharing a celebratory piece of birthday cake with their cherished horse vet!”
You can see the 60 Faces here: https://www.beva.org.uk/60-Faces
Boehringer Ingelheim Vetmedica, manufacturer of the equine pergolide Prascend, has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the 'Talk About Cushing's (TAC)' campaign.
The initiative, which will take place throughout September and October 2011, is aimed at raising awareness of Cushing's Disease and its clinical signs, perhaps the most familiar of which is hirsutism (abnormal hair growth, or delayed shedding). Horse owners can download a £15 money-off voucher from http://www.talkaboutcushings.co.uk/ throughout the TAC initiative, which can be redeemed through their veterinary practice against blood test costs.
Boehringer says Equine Cushing's Disease, also known as Pituitary Pars Intermedia Dysfunction (PPID), is the most common endocrine disorder in older horses and ponies1 ,and that some estimates suggest over 15% of horses and ponies over 15 years of age are affected2.
Unfortunately, the initial stages of Cushing's Disease are often difficult to detect, delaying the maximum benefit of early diagnosis and intervention. Blood testing is increasingly used to detect the disease and confirm diagnosis, however many horses with clinical signs, including recurrent laminitis, still go undiagnosed.
Craig Beck, vet and equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "More than 80% of horses suffering from laminitis may have an underlying endocrine disorder, such as Cushing's Disease3.
"The TAC campaign will raise awareness of Cushing's Disease amongst both veterinary professionals and owners. It should make it easier for vets to go ahead with endocrine testing in horses and ponies with recurrent laminitis, diagnosing and treating earlier in the course of the disease."
Lee Hackett, head of welfare at the BHS, added: "Cushing's Disease is relatively common in horses yet in our experience it frequently goes undiagnosed and untreated. This is why we are fully behind the 'Talk About Cushing's' campaign - anything that raises awareness and understanding of this disease has to be of benefit to equine welfare."
Redwings' head of veterinary services Nicky Jarvis said: "At Redwings we have many horses over the age of 15, all living very happy and healthy lives. 'Old age' is not in itself a disease so when a geriatric horse loses condition or appears unwell there is always an underlying cause. If a horse continually succumbs to laminitis or loses weight, Cushing's Disease could be one explanation. However, with early diagnosis, good management and the correct treatment a horse with Cushing's can live comfortably for many years."
"Early diagnosis of Cushing's Disease can be of great benefit, other conditions such as laminitis are often associated with it and it is important that clinical signs are recognised and treated appropriately. World Horse Welfare supports the 'Talk About Cushing's' campaign as it will help people to recognise the signs and take the right action to prevent horses from suffering," concludes Tony Tyler, deputy chief executive, World Horse Welfare.
Backed by an advertising and PR campaign in the equine consumer media, Boehringer Ingelheim Vetmedica has produced a marketing pack for veterinary practices to use in the run up to, and during TAC. This includes leaflets, invoice stickers, a veterinary practice toolkit featuring an owner evening presentation, editorial copy for newsletters and websites and images to support the campaign.
For further information on TAC or Prascend, the first licensed product for the treatment of Cushing's Disease, please visit http://www.talkaboutcushings.co.uk/, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
1. Donaldson et al. “Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis”. JAVMA, Vol 224, No. 7, April 1, 20042. McGowan. “Diagnostic and Management Protocols for Equine Cushings Syndrome” In Practice, November/December 20033. McGowan. “Epidemiology and Clinical Perspectives of Endocrinopathic Laminitis”, BEVA Congress 2009
Every UK-based veterinary surgeon that registers as a member of www.vetsurgeon.org by 1st November 2010 will be entered into a draw to win an Apple iPad 32GB Wi-Fi worth £500.
All existing veterinary surgeon members will also be entered into the draw automatically, so there's no need to re-register. Still, you might like to spread the word about the draw amongst colleagues.
Full terms and conditions are available by clicking here.